Immuno-oncology - December 2021
We only have one FDA-approved immunotherapy for prostate cancer, Provenge (sipuleucel-T). However, that may be about to change. Research on how to harness the immune system to treat cancer is … more
We only have one FDA-approved immunotherapy for prostate cancer, Provenge (sipuleucel-T). However, that may be about to change. Research on how to harness the immune system to treat cancer is … more
This month, we’re talking about our understanding of the genetic and molecular mechanisms driving prostate cancer. If we can understand how cancer differs from your body’s normal tissues, we can … more